Plasma
Back to Test Catalogue
Eculizumab (Soliris) – Free, Plasma
Test ID: ECULISO P
Test
Method
ELISA
Specimens
Clinical Utility
Eculizumab is a monoclonal antibody that blocks the terminal complement activation pathway. This medication is primarily used to treat diseases related to overactivation of the alternative complement pathway, such as paroxysmal nocturnal hemoglobinuria, membranoproliferative glomerulonephritis, and atypical hemolytic uremic syndrome.
Test Version
19-Nov-2025
Specimen
Specimens
Plasma
Collection Containers
Blue top (3.2% buffered citrate)
Sample Volume
2 x 0.5 mL
Collection & Handling
Handling Information
Double centrifuged plasma, transported on dry ice.
Stability
| Ambient | 2 hours |
|---|---|
| Frozen | > 2 hours |
Test Version
19-Nov-2025
Performance / Interpretation
Method
ELISA
Turnaround Time
25 days
Results
| Name | Units | Reference Range | Conversion Factor | |
|---|---|---|---|---|
|
||||
Test Version
19-Nov-2025
Interface / Setup
Test Version
19-Nov-2025